Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-16

Clinical Trial Update: Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing levocetirizine with loratadine for perennial allergic rhinitis has completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loratadine (Loratadine)
  • XYZAL (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

Sponsor: UCB Pharma | Conditions: Rhinitis, Allergic | Phase 3 | Status: COMPLETED